Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
weight loss accelerates 72w 72 Weeks Average 20.9% body weight lost at 15 mg dose in SURMOUNT-1 trial Eligibility Who Qualifies BMI of 30 or higher (obesity classification) BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea No personal or family history of medullary thyroid cancer No history of multiple endocrine neoplasia syndrome type 2 Not currently pregnant, planning pregnancy, or breastfeeding No prior severe allergic reaction to tirzepatide Your Program Common Side Effects Most side effects are gastrointestinal, mild to moderate in severity, and tend to resolve as your body adjusts during the first several weeks
[2] : [1][2]
We package your CJC-1295+ipamorelin peptide strips with care to ensure they arrive in perfect condition
The triple-action mechanism might require different dose adjustments compared to dual agonists
Qu pasa con los efectos a largo plazo
